Faculty Information |
|
Article types | Original article |
Language | English |
Refereed paper | Not refereed |
Title | Is Noncurative Hepatic Resection Justified for Advanced Hepatocellular Carcinoma? |
Journal | Formal name:The American surgeon Abbreviation:Am Surg ISSN code:1555982300031348 |
Domestic / Foregin | Foregin |
Volume, Number, Page | 84(12),pp.1938-44 |
Papers・Author | Hai Seikan, Hatano Etsuro, Okada Toshihiro, Uyama Naoki, Suzumura Kazuhiro, Fujimoto Jiro |
Publication date | 2018/12 |
Papers・Description | It has been obscure whether or not noncurative hepatic resection (Hx) has a favorable impact on the clinical course in patients with advanced hepatocellular carcinoma (HCC). The aim of this study is to clarify the significance of noncurative Hx for advanced HCC. Among 666 consecutive patients undergoing Hx for HCC in our department, 79 patients underwent noncurative Hx. These patients were classified as Group A (presence of macrovascular invasion [MVI]; n = 29), Group B (residual tumors in the remnant liver; n = 37), Group C (residual tumors in the remnant liver with MVI; n = 7), or Group D (residual tumors in the remnant liverwith distant metastasis [with or without MVI]; n = 6). The three-year survival rates were 49.6 per cent in Group A, 30.3 per cent in Group B, 14.3 per cent in Group C, and 0.0 per cent in Group D, respectively (Groups A and Bvs |
PMID | 30606352 |